Wacker Chemie Confirms Broad-Based Revenue Decline Across All Divisions

Wacker Chemie reports 2025 sales decline across all segments due to high energy costs and weak demand. Despite challenges, it plans €300M in 2026 investments, forecasting low single-digit revenue growth.

The German specialty chemicals group Wacker Chemie AG has reported a contraction in sales for the year 2025, with every one of its four core business segments registering a downturn. Management cited persistent headwinds, including elevated energy costs, structural overcapacity in the industry, and tepid market demand. Despite this challenging environment, the company has outlined targeted investment plans for the coming year.

Management Outlines Investment Strategy Amid Challenges

Even against a backdrop of financial pressure, Wacker Chemie's balance sheet provides some flexibility for strategic moves. The company concluded 2025 with net financial debt of €886 million and a solid equity ratio of 45 percent. Intending to leverage this position, management has approved capital expenditure plans of approximately €300 million for 2026.

These investments are earmarked for projects such as new silicone production facilities and a biotechnology center in Munich. For the full year 2026, the group anticipates revenue growth in the low single-digit percentage range. It forecasts EBITDA to land between €550 million and €700 million.

Segment Performance Reflects Industry-Wide Weakness

A detailed review of the company’s portfolio reveals a consistent pattern of decline, underscoring the breadth of current market difficulties. The performance across all divisions was negative.

• The largest segment, Silicones, saw revenue fall by three percent to €2.73 billion.
• Revenue from the Polymers division contracted by six percent to €1.38 billion.
• The Biosolutions business reported a four percent decline.
• The most significant percentage drop was in Polysilicon, where sales decreased by seven percent to €883 million.

Company executives attributed the widespread softness to persistently weak demand, ongoing geopolitical tensions, and structural competitive disadvantages at its European production sites. The dual burden of high regional energy prices and substantial overcapacity in standard chemicals was highlighted as a particular strain.

Market Reaction and Technical Position

The financial update was met with a negative response in the trading session. Wacker Chemie shares declined roughly seven percent to €74.75. The stock's Relative Strength Index (RSI) reading of 28.5 indicates it is in technically oversold territory. Whether this condition precedes a stabilization will largely depend on the company's ability to meet its 2026 guidance.